Remoxipride
From Self-sufficiency
File:Remoxipride Structural Formulae.png | |
Systematic (IUPAC) name | |
---|---|
(S)-3-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,6-dimethoxy-benzamide | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 117591-79-4 |
ATC code | N05AL04 (WHO) |
PubChem | CID 54477 |
DrugBank | DB00409 |
Chemical data | |
Formula | C16H23BrN2O3 |
Molar mass | 371.27 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Remoxipride (Roxiam) is an atypical antipsychotic which was previously used in Europe for the treatment of schizophrenia but was withdrawn due to toxicity concerns (incidence of aplastic anemia in 1/10,000 patients).[1] It was initially launched by AstraZeneca in 1990 and suspension of its use began in 1993.[1] Remoxipride acts as a selective D2 and D3 receptor antagonist and also has high affinity for the sigma receptor, possibly playing a role in its atypical neuroleptic action.[2]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
- ↑ 1.0 1.1 José Miguel Vela; Helmut Buschmann; Jörg Holenz; Antonio Párraga; Antoni Torrens (2007). Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. Weinheim: Wiley-VCH. ISBN 3-527-31058-4.
- ↑ Köhler C, Hall H, Magnusson O, Lewander T, Gustafsson K (1990). "Biochemical pharmacology of the atypical neuroleptic remoxipride". Acta Psychiatrica Scandinavica. Supplementum. 358: 27–36. PMID 1978484.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Atypical antipsychotics
- Pyrrolidines
- Benzamides
- Phenol ethers
- Organobromides
- Nervous system drug stubs
- 2Fix
- CS1 maint: Multiple names: authors list